Regencell Bioscience Holdings Ltd. RGC
$17.51
▼ -4.37% 24H
About
Regencell Bioscience Holdings Ltd. is a bioscience company specializing in the research, development, and commercialization of Traditional Chinese Medicine (TCM) formulations. It targets neurocognitive disorders and degenerations, with a primary focus on Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectr…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryHong Kong
Employees10
TickerRGC
Statistics
Market Cap$8.66B
Revenue (TTM)—
Net Income-$3.6M
Net Margin—
EPS$-0.72
P/E-2725.00
P/S—
P/B10155.00
EV/EBITDA-1421.08
ROE-177.7%
Dividend Yield—
Price$17.51
Data: Twelve Data · Revenue = mcap / P/S